Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-07

Clinical Trial Update: Analgosedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an analgosedative adjunct ketamine infusion in mechanically ventilated ICU patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Analgesedative adjuncT keTAmine infusion (ketamine infusion)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Critical Illness, Sedation | Phase 3 | Status: COMPLETED